152 related articles for article (PubMed ID: 38081464)
1. Healthcare resource utilization for chronic low back pain among high-utilizers.
Kirsch EP; Yang LZ; Lee HJ; Parente B; Lad SP
Spine J; 2024 Apr; 24(4):601-616. PubMed ID: 38081464
[TBL] [Abstract][Full Text] [Related]
2. Health Care Resource Utilization of High-Frequency Spinal Cord Stimulation for Treatment of Chronic Refractory Low Back Pain.
Rajkumar S; Yang LZ; Venkatraman V; Charalambous L; Parente B; Lee HJ; Lad SP
Neuromodulation; 2023 Jan; 26(1):115-123. PubMed ID: 35871122
[TBL] [Abstract][Full Text] [Related]
3. Economic Burden of Irritable Bowel Syndrome with Diarrhea: Retrospective Analysis of a U.S. Commercially Insured Population.
Buono JL; Mathur K; Averitt AJ; Andrae DA
J Manag Care Spec Pharm; 2017 Apr; 23(4):453-460. PubMed ID: 28345443
[TBL] [Abstract][Full Text] [Related]
4. Healthcare resource utilization and costs 2 years pre- and post-lumbar spine surgery for stenosis: a national claims cohort study of 22,182 cases.
Koltsov JCB; Sambare TD; Alamin TF; Wood KB; Cheng I; Hu SS
Spine J; 2022 Jun; 22(6):965-974. PubMed ID: 35123048
[TBL] [Abstract][Full Text] [Related]
5. Nonoperative care to manage sacroiliac joint disruption and degenerative sacroiliitis: high costs and medical resource utilization in the United States Medicare population.
Ackerman SJ; Polly DW; Knight T; Holt T; Cummings J
J Neurosurg Spine; 2014 Apr; 20(4):354-63. PubMed ID: 24527824
[TBL] [Abstract][Full Text] [Related]
6. Administrative claims analysis of all-cause annual costs of care and resource utilization by age category for ulcerative colitis patients.
Bickston SJ; Waters HC; Dabbous O; Tang BI; Rahman M
J Manag Care Pharm; 2008 May; 14(4):352-62. PubMed ID: 18500913
[TBL] [Abstract][Full Text] [Related]
7. Patients with Idiopathic Membranous Nephropathy: A Real-World Clinical and Economic Analysis of U.S. Claims Data.
Nazareth TA; Kariburyo F; Kirkemo A; Xie L; Pavlova-Wolf A; Bartels-Peculis L; Vaidya N; Sim JJ
J Manag Care Spec Pharm; 2019 Sep; 25(9):1011-1020. PubMed ID: 31283419
[TBL] [Abstract][Full Text] [Related]
8. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
[TBL] [Abstract][Full Text] [Related]
9. The Economic Burden of End-Organ Damage Among Medicaid Patients with Sickle Cell Disease in the United States: A Population-Based Longitudinal Claims Study.
Campbell A; Cong Z; Agodoa I; Song X; Martinez DJ; Black D; Lew CR; Varker H; Chan C; Lanzkron S
J Manag Care Spec Pharm; 2020 Sep; 26(9):1121-1129. PubMed ID: 32597290
[TBL] [Abstract][Full Text] [Related]
10. Clinical and Economic Burden of Commercially Insured Patients with Acromegaly in the United States: A Retrospective Analysis.
Placzek H; Xu Y; Mu Y; Begelman SM; Fisher M
J Manag Care Spec Pharm; 2015 Dec; 21(12):1106-12. PubMed ID: 26679960
[TBL] [Abstract][Full Text] [Related]
11. Healthcare resource utilization and costs in patients with a newly confirmed diagnosis of lupus nephritis in the United States over a 5-year follow-up period.
Bell CF; Wu B; Huang SP; Rubin B; Averell CM; Chastek B; Hulbert EM
BMC Health Serv Res; 2024 May; 24(1):691. PubMed ID: 38822336
[TBL] [Abstract][Full Text] [Related]
12. The burden of chronic low back pain with and without a neuropathic component: a healthcare resource use and cost analysis.
Mehra M; Hill K; Nicholl D; Schadrack J
J Med Econ; 2012; 15(2):245-52. PubMed ID: 22136441
[TBL] [Abstract][Full Text] [Related]
13. Health care resources and costs for treating peripheral artery disease in a managed care population: results from analysis of administrative claims data.
Margolis J; Barron JJ; Grochulski WD
J Manag Care Pharm; 2005; 11(9):727-34. PubMed ID: 16300416
[TBL] [Abstract][Full Text] [Related]
14. Healthcare Resource Use and Costs Associated with Opioid Initiation Among Patients with Newly Diagnosed Endometriosis with Commercial Insurance in the USA.
Estes SJ; Soliman AM; Zivkovic M; Chopra D; Zhu X
Adv Ther; 2020 Jun; 37(6):2777-2791. PubMed ID: 32399813
[TBL] [Abstract][Full Text] [Related]
15. Actuarial analysis of private payer administrative claims data for women with endometriosis.
Mirkin D; Murphy-Barron C; Iwasaki K
J Manag Care Pharm; 2007 Apr; 13(3):262-72. PubMed ID: 17407392
[TBL] [Abstract][Full Text] [Related]
16. Healthcare Utilization and Costs Associated with New-Onset Pain in a Medicare Population.
Staats PS; Patel K; Gillen EM; Bello T; Epple T; Bilder SM; Wisor D
Pain Physician; 2022 Dec; 25(9):E1415-E1422. PubMed ID: 36608013
[TBL] [Abstract][Full Text] [Related]
17. Real-world practice patterns, health-care utilization, and costs in patients with low back pain: the long road to guideline-concordant care.
Ivanova JI; Birnbaum HG; Schiller M; Kantor E; Johnstone BM; Swindle RW
Spine J; 2011 Jul; 11(7):622-32. PubMed ID: 21601533
[TBL] [Abstract][Full Text] [Related]
18. Covariates of depression and high utilizers of healthcare: Impact on resource use and costs.
Robinson RL; Grabner M; Palli SR; Faries D; Stephenson JJ
J Psychosom Res; 2016 Jun; 85():35-43. PubMed ID: 27212668
[TBL] [Abstract][Full Text] [Related]
19. Initial management decisions after a new consultation for low back pain: implications of the usage of physical therapy for subsequent health care costs and utilization.
Fritz JM; Brennan GP; Hunter SJ; Magel JS
Arch Phys Med Rehabil; 2013 May; 94(5):808-16. PubMed ID: 23337426
[TBL] [Abstract][Full Text] [Related]
20. The burden of chronic low back pain: clinical comorbidities, treatment patterns, and health care costs in usual care settings.
Gore M; Sadosky A; Stacey BR; Tai KS; Leslie D
Spine (Phila Pa 1976); 2012 May; 37(11):E668-77. PubMed ID: 22146287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]